Phytoestrogens: The biochemistry, physiology, and implications for human health of soy isoflavones

American Journal of Clinical Nutrition

Volumn 68, Issue 6 SUPPL., 1998, Pages

  Setchell, Kenneth D R ^a  

^a CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER   (United States)

Author keywords

Cancer; Cardiovascular disease; Menopause; Phytoestrogens; Soy isoflavones

Indexed keywords

ALPHA RESORCYLIC ACID; DAIDZEIN; ESTRADIOL; GENISTEIN; ISOFLAVONE; LIGNAN; PHYTOESTROGEN; SOYBEAN PROTEIN;

ANTINEOPLASTIC ACTIVITY; BIOCHEMISTRY; BIOTRANSFORMATION; BREAST CANCER; CARDIOVASCULAR DISEASE; CHOLESTEROL METABOLISM; CONFERENCE PAPER; DIETARY INTAKE; FRUIT; HEALTH; HUMAN; INTESTINE FLORA; NONHUMAN; OSTEOPOROSIS; PHYSIOLOGY; POSTMENOPAUSE; PROSTATE CANCER; SOYBEAN; URINARY EXCRETION; VEGETABLE;

GLYCINE MAX;

EID: 0031741906     PISSN: 00029165     EISSN: None     Source Type: Journal    
DOI: 10.1093/ajcn/68.6.1333S     Document Type: Conference Paper

References (226)

1. National Academy of Sciences. Diet, nutrition, and cancer. Washington, DC: National Academy Press, 1982.
2. Bradbury RB, White DE. Oestrogens and related substances in plants. Vitam Horm 1954;12:207-33.
3. Farnsworth NR, Bingel AS, Cordell GA, Crane FA, Fong HHS. Potential value of plants as sources of new antifertility agents II. J Pharm Sci 1975;64:717-54.
4. Cheng E, Yoder L, Story CD, Burrough W. Estrogenic activity of some isoflavone derivatives. Science 1954;120:575-6.
5. Stob M. Naturally occurring food toxicants: oestrogens. In: Rechcigl M Jr, ed. Handbook of naturally occurring food toxicants. Boca Raton, FL: CRC Press, 1983:81-100.
6. Setchell KDR. Naturally occurring non-steroidal estrogens of dietary origin. In: McLachlan J, ed. Estrogens in the environment: influence on development. New York: Elsevier, 1985:69-85.
7. Price KR, Fenwick GR. Naturally occurring oestrogens in foods: a review. Food Addit Contam 1985;2:73-106.
8. McLachlan J. Estrogens in the environment: influence on development. New York: Elsevier, 1985.
9. Leclerq G, Heuson JC. Physiological and pharmacological effects of estrogens in breast cancer. Biochim Biophys Acta 1979;560:427-55.
10. Shemesh M, Lindner HR, Ayalon N. Affinity of rabbit uterine oestradiol receptor for phytooestrogens and its use in a competitive protein binding radioassay for plasma coumestrol. J Reprod Fertil 1972;29:1-9.
11. Verdeal K, Brown RR, Richardson T, Ryan DS. Affinity of phytoestrogen for estradiol-binding proteins and effect of coumestrol on growth of 7,12-dimethylbenz[a]anthracene-induced rat mammary tumors. J Natl Cancer Inst 1980;64:285-90.
12. Barnes S, Peterson TG. Biochemical targets of the isoflavone genistein in tumor cell lines. Proc Soc Exp Biol Med 1995;208:103-8.
13. Makela SI, Pylkkanen LH, Santti RS, Adlercreutz H. Dietary soybean may be antiestrogenic in male mice. J Nutr 1994;125:437-45.
14. Makela S, Santti R, Salo L, McLachlan JA. Phytoestrogens are partial estrogen agonists in the adult male mouse. Environ Health Perspect 1995;103:123-7.
15. Kuiper GGJM, Enmark E, Peltohuikki M, Nilsson S, Gustaffson JA. Cloning a novel estrogen receptor expressed in rat prostate and ovary. Proc Natl Acad Sci U S A 1996;93:5925-30.
16. Kuiper GGJM, Carlsson B, Grandien K, et al. Comparison of the ligand binding specificity and transcript tissue distribution of estrogen receptors alpha and beta. Endocrinology 1997;138:863-70.
17. Setchell KDR, Lawson AM, Mitchell FL, Adlercreutz H, Kirk DN, Axelson M. Lignans in man and animal species. Nature 1980;287:740-2.
18. Setchell KDR, Lawson AM, Conway E, et al. The definitive identification of the lignans trans-2,3-bis(3-hydroxybenzyl)-g-butyrolactone and 2,3-bis(3-hydroxybenzyl) butane-1,4-diol in human and animal urine. Biochem J 1981;197:447-58.
19. Marrian GF, Haslewood GAD. CXLV. Equol, a new inactive phenol isolated from the ketohydroxyoestrin fraction of mares urine. Biochem J 1932;26:1227-32.
20. Axelson M, Kirk DN, Cooley G, Farrant RD, Lawson AM, Setchell KDR. The identification of the weak estrogen equol (7-hydroxy-3-(4′-hydroxyphenyl) chroman) in human urine. Biochem J 1982;201:353-7.
21. Folman Y, Pope GS. The interaction in the immature mouse of potent oestrogens with coumestrol, genistien and other utero-vaginotrophic compounds of low potency. J Endocrinol 1966; 34:215-25.
22. Braden AWH, Hart NK, Lamberton JA. The estrogenic activity and metabolism of certain isoflavones in sheep. Aust J Agric Res 1967;18:335-48.
23. Shutt DA. The effects of plant estrogens on animal reproduction. Endeavour 1976;35:110-3.
24. Shutt DA, Cox RI. Steroid and phytoestrogen binding to sheep uterine receptors in vivo. J Endocrinol 1972;52:299-310.
25. Martin PM, Horwitz KB, Ryan DS, McGuire WL. Phytoestrogen interaction with estrogen receptors in human breast cancer cells. Endocrinology 1978;103:1860-7.
26. Tang BY, Adams NR. The effect of equol on oestrogen receptors and on synthesis of DNA and protein in immature rat uterus. J Endocrinol 1980;85:291-7.
27. Farmakalidis E, Hathcock JN, Murphy PA. Oestrogenic potency of genistin and daidzin in mice. Food Chem Toxicol 1985;23:741-5.
28. Markiewicz L, Garey J, Adlercreutz H, Gurpide E. In vitro bioassays of non-steroidal phytoestrogens. J Steroid Biochem Mol Biol 1993;45:399-405.
29. Molteni A, Brizio-Molteni L, Persky V. In vitro hormonal effects of soybean isoflavones. J Nutr 1995;125:751S-6S.
30. Nagel SE, vonSaal FF, Welshons WV. The effective free fraction of estradiol and xenoestrogens in human serum measured by whole cell uptake assays; physiology of delivery modifies estrogenic activity. Proc Soc Exp Biol Med 1998;217:300-9.
31. Setchell KDR, Adlercreutz H. Mammalian lignans and phyto-oestrogens. Recent studies on their formation, metabolism and biological role in health and disease. In: Rowland IA, ed. The role of gut microflora in toxicity and cancer. New York: Academic Press, 1988:315-45.
32. Setchell KDR. Non-steroidal estrogens of dietary origin: possible roles in health and disease, metabolism and physiological effects. Proc Nutr Soc N Z 1995;20:1-21.
33. Adlercreutz H. Phytoestrogens: epidemiology and a possible role in cancer protection. Environ Health Perspect 1995;103:103-12.
34. AkiyamaT, Ishida J, Nakagawa S, et al. Genistein: a specific inhibitor of tyrosine-specific protein kinase. J Biol Chem 1987;262:5592-5.
35. Kim H, Peterson TG, Barnes S. Mechanisms of action of the soy isoflavone genistein: emerging role for its effects via transforming growth factor β signaling pathways. Am J Clin Nutr 1998;68 (suppl); 1418S-25S.
36. Peterson TG, Barnes S. Genistein inhibition of the growth of human breast cancer cells: independence from estrogen receptors and the multi-drug resistance gene. Biochem Biophys Res Commun 1991;179:661-7.
37. Peterson TG, Barnes S. Isoflavones inhibit growth of human prostate cancer cells lines without inhibiting epidermal growth factor receptor auto-phosphorylation. Prostate 1993;22:335-45.
38. Hahlbrock K. Flavonoids. In: Conn EE, ed. The biochemistry of plants: a comprehensive treatise-secondary plant products. New York: Academic Press, 1981;7:425-56.
39. Ebel J, Grisebach H, Bonhoff A, et al. Phytoalexin synthesis in soybean following infection of roots with fungal elicitor. In: Lugtenberg B, ed. Recognition in microbe-plant symbiotic and pathogenic interations: NATO Advanced Research Workshop. New York: Springer Verlag, 1986:345-61. [NATO ASI (Advanced Science Institutes) Series H, Vol 4.]
40. Rolfe BG. Flavones and isoflavones as inducing substances of legume nodulation. Biofactors 1988;1:3-10.
41. Ayres DC, Loike JD. Lignans. Chemical, biological and clinical properties. Cambridge, United Kingdom: Cambridge University Press, 1990.
42. Axelson M, Sjovall J, Gustafsson BE, Setchell KDR. Origin of lignans in mammals and identification of a precursor from plants. Nature 1982;298:659-60.
43. Setchell KDR. Discovery and potential clinical importance of mammalian lignans. In: Cunnane SS, Thompson LU, eds. Flaxseed in human nutrition. Champaign, IL: AOCS Press 1995:82-98.
44. Walz E. Isoflavone: a saponin glucoside in soya. Justus Liebigs Ann Chem 1931;489:118-55 (in German).
45. Walter ED. Genistein (an isoflavone glucoside) and its aglucone, genistein, from soybeans. J Am Oil Chem Soc 1941;63:3273-6.
46. Naim M, Gestetner B, Zilkah S, Birk Y, Bondi A. Soybean isoflavones, characterization, determination, and antifungal activity. J Agric Food Chem 1974;22:806-10.
47. Murphy PA. Phytoestrogen content of processed soybean products. Food Technol 1982;34:60-4.
48. Eldridge AC. Determination of isoflavones in soybean flours, protein concentrates and isolates. J Agric Food Chem 1982;30:353-5.
49. Coward L, Barnes NC, Setchell KDR, Barnes S. Genistein and daidzein, and their β-glycoside conjugates: anti-tumor isoflavones in soybean foods from American and Asian diets. J Agric Food Chem 1993;41:1961-7.
50. Wang H-J, Murphy PA. Isoflavone content in commercial soybean foods. J Agric Food Chem 1994;42:1666-73.
51. Franke AA, Custer LJ, Cerna CM, Narala K. Rapid HPLC analysis of dietary phytoestrogens from legumes and from human urine. Proc Soc Exp Biol Med 1995;208:18-26.
52. Axelson M, Sjovall J, Gustafsson B, Setchell KDR. Soya - a dietary source of the non-steroidal oestrogen equol in humans and animals. J Endocrinol 1984;102:49-56.
53. Setchell KD, Borriello SP, Hulme P, Kirk DN, Axelson M. Nonsteroidal estrogens of dietary origin: possible roles in hormone-dependent disease. Am J Clin Nutr 1984;40:569-78.
54. Setchell KDR, Lawson AM, Borriello SP, et al. Lignan formation in man: microbial involvement and possible roles in relation to cancer. Lancet 1981;2:4-8.
55. Adlercreutz H. Does fiber-rich food containing animal lignan precursors protect against both colon and breast cancer? An extension of the "fiber hypothesis". Gastroenterology 1984;86:761-4.
56. Messina M, Messina V, Setchell KDR. The simple soybean and your health. Garden City Park, NY: Avery Publishing Group, 1994.
57. Adlercreutz H. Western diet and Western diseases: some hormonal and biochemical mechanisms and associations. Scand J Clin Lab Invest 1990;201:3-21.
58. Messina M, Persky V, Setchell KDR, Barnes S. Soy intake and cancer risk: a review of the in vitro and in vivo data. Nutr Cancer 1994;21:113-31.
59. Jones AE, Price KR, Fenwick GR. Development and application of a high-performance liquid chromatographic method for the analysis of phytoestrogens. J Sci Food Agric 1989;46:357-64.
60. Messina M, Messina V. Increasing use of soyfoods and their potential role in cancer prevention. J Am Diet Assoc 1991;91:836-40.
61. Hadfield P. Japanese swallow Western diseases. New Scientist 1995;Sept 2:5.
62. Cunnane SS, Thompson LU. Flaxseed in human nutrition. Champaign, IL: AOCS Press, 1995.
63. Dwyer JT, Goldin BR, Saul N, Gualtieri L, Barakat S, Adlercreutz H. Tofu and soy drinks contain phytoestrogens. J Am Diet Assoc 1994;94:739-43.
64. Eldridge A, Kwolek WF. Soybean isoflavones: effect of environment and variety on composition. J Agri Food Chem 1983; 31:394-6.
65. Seo A, Morr CV. Improved high-performance liquid chromatographic analysis of phenolic acids and isoflavonoids from soybean protein products. J Agric Food Chem 1984;32:530-3.
66. Setchell KDR, Welsh MB, Lim CK. HPLC analysis of phytoestrogens in soy protein preparations with ultraviolet, electrochemical, and thermospray mass spectrometric detection. J Chromatogr 1987;385:267-74.
67. Barnes S, Kirk M, Coward L. Isoflavones and their conjugates in soy foods: extraction conditions and analysis by HPLC-mass spectrometry. J Agric Food Chem 1994;42:2466-74.
68. Setchell KDR, Nechemias-Zimmer LZ, Cai J, Heubi JE. Exposure of infants to phytoestrogens from soy infant formulas. Lancet 1997;350:23-7.
69. Farmakalidis E, Murphy PA. Isolation of 6″-O-acetyldaidzein and 6″-O-acetylgenistein from toasted defatted soy flakes. J Agric Food Chem 1985;33:385-9.
70. Kudou S, Flueury Y, Welti D, et al. Malonyl isoflavone glycosides in soybean seeds (Glycine max MERRILL). Agric Biol Chem 1991;55:2227-33.
71. Naim M, Gestetner B, Kirson I, Birk Y, Bondi A. A new isoflavone from soyabean. Phytochemistry 1973;12:169-70.
72. Lu L-JW, Broemelin LD, Marshall MV, Sadagopa Ramanujam VM. A simplified method to quantify isoflavones in commercial soybean diets and human urine after legume consumption. Cancer Epidemiol Biomarkers Prev 1995;4:497-503.
73. Cruz ML, Wong WW, Mimouni F, et al. Effects of infant nutrition on cholesterol synthesis rates. Pediatr Res 1994;35:135-40.
74. Whitten PL, Lewis C, Russell E, Naftolin F. Potential adverse effects of phytoestrogens. J Nutr 1995;125:7715-65.
75. Irvine C, Fitzpatric M, Robertson I, Woodhams D. The potential adverse effects of soybean isoflavones in infant feeding. N Z Med J 1995;108:218 (letter).
76. Barrett J. Phytoestrogens: friends or foes? Environ Health Perspect 1996;104:478-82.
77. Klus K, Barz W. Formation of polyhydroxylated isoflavones from the soybean seed isoflavones daidzein and glycitein by bacteria isolated from tempe. Arch Microbiol 1995;164:428-34.
78. Axelson M, Setchell KDR. Conjugation of lignans in human urine. FEBS Lett 1980;122:49-53.
79. Axelson M, Setchell KDR. The excretion of lignans in rats: evidence for an intestinal bacterial source for this new group of compounds. FEBS Lett 1981;123:337-42.
80. Klyne W, Wright AA. Steroids and other lipids of pregnant goat's urine. Biochem J 1957;66:92-101.
81. Klyne W, Wright AA. Steroids and other lipids of pregnant cows' urine. J Endocrinol 1959;18:32-45.
82. MacRae HF, Dale DG, Common RH. Formation in vivo of 16-epiestriol and 16-keto-estradiol-17β from estriol by the laying hen and occurrence of equol of hen's urine and feces. Can J Biochem Physiol 1960;38:523-32.
83. Common RH, Aimsworth L. Identification of equol in the urine of the domestic fowl. Biochim Biophys Acta 1961;53:403-4.
84. Shutt DA, Braden AWH. The significance of equol in relation to the oestrogenic responses in sheep ingesting clover with a high formononetin content. Aust J Agric Res 1968;19:545-53.
85. Yasuda T, Kano Y, Saito K, Ohsawa K. Urinary and biliary metabolites of daidzin and daidzein in rats. Biol Pharm Bull 1994;17: 1369-74.
86. Morton MS, Wilcox G, Wahlqvist ML, Griffiths K. Determination of lignans and isoflavonoids in human female plasma following dietary supplementation. J Endocrinol 1994;142:251-9.
87. Xu X, Harris KS, Wang H-J, Murphy PA, Hendrich S. Bioavailability of soybean isoflavones depends upon gut microflora in women. J Nutr 1995;125:2307-45.
88. Kurzer MS, Lampe JW, Martini MC, Adlercreutz H. Fecal lignan and isoflavonoid excretion in premenopausal women consuming flaxseed powder. Cancer Epidemiol Biomarkers Prev 1995;4:353-8.
89. King RA, Broadbent JL, Head RJ. Absorption and excretion of the soy isoflavone genistein in rats. J Nutr 1996;126:176-82.
90. Sfakianos J, Coward L, Kirk M, Barnes S. Intestinal uptake and biliary excretion of the isoflavone genistein in the rat. J Nutr 1997;127:1260-8.
91. Borriello SP, Setchell KDR, Axelson M, Lawson AM. Production and metabolism of lignans by the human faecal flora. J Appl Bacteriol 1985;58:37-43.
92. Clerici C, Gentilli G, Distrutti E, et al. Effect of dietary estrogens on bile-flow and biliary lipids. Hepatology 1992;16:255A (abstr).
93. Adlercreutz H. Studies on oestrogen excretion in human bile. Acta Endocrinol Suppl (Copenh) 1962;72:1-220.
94. Adlercreutz H, Martin F. Biliary excretion and intestinal metabolism of progesterone and estrogens in man. J Steroid Biochem 1980;13:231-44.
95. Mackenzie PI,Rodbourne L, Stranks S. Steroid UDP glucuronosyl-transferases. Steroid Biochem Mol Biol 1992;43:1099-105.
96. Martucci CP, Fishman J. P450 enzymes of estrogen metabolism. Pharmacol Ther 1993;57:237-57.
97. Setchell KDR. Synthesis of sex hormones. In: Reyes HB, Leuschner U, Arias EM, eds. Pregnancy, sex hormones and the liver. Boston: Kluwer Academic, 1996:3-15.
98. Brunner G, Tegtmeier F, Kirk DN, Wynn S, Setchell KDR. Enzymatic synthesis and chromatographic purification of lignan glucuronides. Biomed Chromatogr 1986;1:89-92.
99. Adlercreutz H, Fotsis T, Lampe J, et al. Quantitative determination of lignans and isoflavones in plasma of omnivorous and vegetarian women by isotope-dilution gas chromatography-mass spectrometry. Scand J Clin Lab Invest 1993;53:5-18.
100. Coward L, Kirk M, Albin N, Barnes S. Analysis of plasma isoflavones by reversed-phase HPLC-multiple reaction ion monitoring-mass spectrometry. Clin Chim Acta 1996;247:121-42.
101. Cox RI, Braden AW. The metabolism and physiological effects of phyto-oestrogens in livestock. Proc Aust Soc Anim 1974;10:122-9.
102. Lundh TJ-O. Metabolism of estrogenic isoflavones in domestic animals. Proc Soc Exp Biol Med 1995;208:33-9.
103. Bennetts HW, Underwood EJ, Shier FL. A specific breeding problem of sheep on subterranean clover pastures in Western Australia. Aust J Agric Res 1946;22:131-8.
104. Lundh TJ-O, Pettersson H, Keissling K-H. Demethylation and conjugation of formononetin and daidzein in sheep and cow liver microsomes. J Agric Food Chem 1988;36:22-5.
105. Lundh TJ-O. Conjugation of the plant estrogens formononetin and daidzein and their metabolite equol by gastrointestinal epithelium from cattle and sheep. J Agric Food Chem 1990;38:1012-6.
106. Adlercreutz H, Fotsis T, Heikkinen R, et al. Diet and urinary excretion of lignans in female subjects. Med Biol 1981;59:259-61.
107. Adlercreutz H, Fotsis T, Heikkinen R, et al. Excretion of the lignans enterolactone, enterodiol and equol in omnivorous and vegetarian women and in women with breast cancer. Lancet 1982;2:1295-9.
108. Adlercreutz H, Fotsis T, Bannwart C, et al. Determination of urinary lignans and phytoestrogen metabolites, potential antiestrogens, and anticarcinogens in urine of women on various habitual diets. J Steroid Biochem 1986;25:791-7.
109. Adlercreutz H, Fotsis T, Hockerstedt K, et al. Diet and urinary estrogen profile in premenopausal omnivorous and vegetarian women and in premenopausal women with breast cancer. J Steroid Biochem 1989;34:527-30.
110. Kelly GE, Joannou GE, Nelson C, Reeder AY, Waring MA. Metabolites of dietary (soya) isoflavones in human urine. Clin Chim Acta 1993;223:9-22.
111. Kelly GE, Joannou GE, Reeder AY, Nelson C, Waring MA. The variable metabolic response to dietary isoflavones in humans. Proc Soc Exp Biol Med 1995;208:40-3.
112. Cassidy A, Bingham S, Setchell KD. Biological effects of soy protein rich in isoflavones on the menstrual cycle of premenopausal women. Am J Clin Nutr 1994;60:333-40.
113. Cassidy A, Bingham S, Setchell KDR. Biological effects of isoflavones in young women: importance of the chemical composition of soybean products. Br J Nutr 1995;74:587-601.
114. Franke AA, Custer LJ. High-performance liquid chromatographic assay of isoflavonoids and coumestrol from human urine. J Chromatogr 1994;662:47-60.
115. Xu X, Wang H-J, Murphy PA, Cook L, Hendrich S. Daidzein is a more bioavailable soy-milk isoflavone than is genistein in adult women. J Nutr 1994;124:825-32.
116. Hutchins AM, Slavin JE, Lampe JW. Urinary isoflavonoid phytoestrogen and lignan excretion after consumption of fermented and unfermented soy products. J Am Diet Assoc 1995;95:545-51.
117. Kirkman LM, Lampe JW, Campbell DR, Martini MC, Slavin JL. Urinary lignan and isoflavonoid excretion in men and women consuming vegetable and soy diets. Nutr Cancer 1995;24:1-12.
118. Bannwart C, Adlercreutz H, Fotsis T, Wahala K, Hase T, Brunow G. Identification of O-desmethylangoIensin, a metabolite of daidzein, and of matairesinol, one likely plant precursor of the animal lignan enterolactone, in human urine. Finn Chem Lett 1984;4-5:120-5.
119. Joannou GE, Kelly GE, Reeder AY, Waring MA, Nelson C. A urinary profile study of dietary phytoestrogens. The identification and mode of metabolism of new isoflavonoids. J Steroid Biochem Mol Biol 1995;54:167-84.
120. Hutchins AM, Lampe JW, Martini MC, Campbell DR, Slavin JL. Vegetables, fruits, and legumes: effect on urinary isoflavonoid phytoestrogen and lignan excretion. J Am Diet Assoc 1995;95:769-74.
121. Adlercreutz H, Honjo H, Higashi A, et al. Urinary excretion of lignans and isoflavone phytoestrogens in Japanese men and women consuming a traditional Japanese diet. Am J Clin Nutr 1991; 54:1093-100.
122. Adlercreutz H, Hamalainen E, Gorbach S, Goldin B. Dietary phytoestrogens and the menopause in Japan. Lancet 1992;339:1233 (letter).
123. Barnes S, Grubbs C, Carlson J, Setchell KDR. Soybeans inhibit mammary tumor growth in models of breast cancer. In: Pariza MW, ed. Mutagens and carcinogens in the diet. New York: Wiley-Liss, 1990:239-53.
124. Adlercreutz H, Fotsis T, Kurzer MS, Wahala K, Makela T, Hase T. Isotope dilution gas chromatographic-mass spectrometric method for the determination of unconjugated lignans and isoflavonoids in human feces, with preliminary results in omnivorous and vegetarian women. Anal Biochem 1995;225:101-8.
125. Lindsay DR, Kelly RW. The metabolism of phyto-oestrogen in sheep. Aust Vet J 1970;46:219-22.
126. Wahala K, Hase T, Adlercreutz H. Synthesis and labeling of isoflavone phytoestrogens, including daidzein and genistein. Proc Soc Exp Biol Med 1995;208:27-32.
127. Setchell KDR, Baraldi PG, Zimmer-Nechemias L, Cai J. Method for the determination of unconjugated isoflavones in human serum by high resolution gas chromatography-mass spectrometry with selected ion monitoring. Proceedings of the 42nd Meeting of the American Society for Mass Spectrometry. San Diego: American Mass Spectrometry Society, 1994:377 (abstr).
128. Barkley MS, Lasley BL, Thompson MA, Shackleton CHL. Equol: a contributor to enigmatic immunoassay measurements of estrogen. Steroids 1985;46:587-608.
129. Adlercreutz H, Markkanen H, Watanabe S. Plasma concentrations of phyto-oestrogens in Japanese men. Lancet 1993;342:1209-10.
130. Leopold AS, Erwin M, Oh J, Browning B. Phytoestrogens: adverse effects on reproduction in California quail. Science 1976;191:98-9.
131. Setchell KDR, Gosselin SJ, Welsh MB, et al. Dietary estrogens: a probable cause of infertility and liver disease in captive cheetahs. Gastroenterology 1987;93:225-33.
132. Kaldas RS, Hughes CL. Reproductive and general metabolic effects of phytoestrogens in mammals. Reprod Toxicol 1989;3:81-9.
133. Whitten PL, Russell E, Naftolin F. Influence of phytoestrogen diets on estradiol action in the rat uterus. Steroids 1994;59:443-50.
134. Fitzhugh OG. Appraisal of the safety of residues of veterinary drugs and their metabolites in edible animal tissues. Ann N Y Acad Sci 1964;111:665-70.
135. Jukes TH. Estrogens in beefsteaks. JAMA 1974;229:1920-1.
136. Jukes TH. Diethylstilbesterol in beef production: what is the risk to consumers? Prev Med 1976;5:438-53.
137. Greenwald P, Nasca PC, Burnett WS, Polan A. Prenatal stilbestrol experience in mothers of young cancer patients. Cancer 1973;31:568-72.
138. Herbst AL, Kurman RJ, Scully RE, Poskaner DC. Clear-cell adenocarcinoma of the genital tract in young females: registry report. N Engl J Med 1972;287:1259-64.
139. Knight DC, Eden JA. Phytoestrogens: a short review. Maturitas 1995;22:167-75.
140. Jordan VC, Koch R, Bain RR. Prolactin synthesis by cultured rat pituitary cells: an assay to study estrogens, antiestrogens and their metabolites in vitro. In: McLachlan JA, ed. Estrogens in the environment. II: Influences on development. New York: Elsevier, 1985:221-34.
141. Walters AP, Knowler JT. Effect of a lignan (HPMF) on RNA synthesis in the rat uterus. J Reprod Fertil 1982;66:379-81.
142. Welshons WV, Murphy CS, Koch R, Calaf G, Jordan VC. Stimulation of the breast cancer cells in vitro by environmental estrogen enterolactone and phytoestrogen equol. Breast Cancer Res Treat 1987;10:169-75.
143. Mousavi Y, Adlercreutz H. Enterolactone and estradiol inhibit each others proliferative effect on MCF-7 breast cancer cells in culture. J Steroid Biochem 1992;41:615-9.
144. Adlercreutz H, Mousavi Y, Clark J, et al. Dietary phytoestrogens and cancer: in vitro and in vivo studies. J Steroid Biochem Mol Biol 1992;41:331-7.
145. Sathyamoorthy N, Wang TTY, Phang JM. Stimulation of pS2 expression by diet-derived compounds. Cancer Res 1994; 54:957-61.
146. Medlock KL, Branham WS, Sheehan DM. The effects of phytoestrogens on neonatal rat uterine growth and development. Proc Soc Exp Biol Med 1995;208:307-13.
147. Troll WR, Wiesner CJ, Shellabarger S, Holtzman S, Stone JP. Soybean diet lowers breast tumor incidence in irradiated rats. Carcinogenesis 1980;1:469-72.
148. Hawrylewicz EJ, Huanag HH, Blair WH. Dietary soybean isolate and methionine supplementation affect mammary tumor progression in rats. J Nutr 1991;121:1693-8.
149. Giri AK, Lu L-J W. Genetic damage and the inhibition of 7,12-dimethylbenz[a]anthracene-induced genetic damage by the phytoestrogens, genistein and daidzein, in female ICR mice. Cancer Lett 1995;95:125-33.
150. Lamartiniere CA, Moore JB, Brown NM, Thompson R, Hardin MJ, Barnes S. Genistein suppresses mammary cancer in rats. Carcinogenesis 1995;16:2833-40.
151. Lamartiniere CA, Moore JB, Holland M, Barnes S. Neonatal genistein chemo prevents mammary cancer. Proc Soc Exp Biol Med 1995;208:120-3.
152. Hirayama T. A large scale cohort study on cancer risks by diet with special reference to the risk reducing effects of green-yellow vegetable consumption. In: Hayashi Y et al, eds. Diet, nutrition and cancer. Utrecht, Netherlands: Sci Press. 1986:41-53.
153. Lee HP, Gourley L, Duffy SW. Dietary effects on breast cancer risk in Singapore. Lancet 1991;337:1197-200.
154. Horn-Ross PL. Phytoestrogens, body composition, and breast cancer. Cancer Causes Control 1995;6:567-73.
155. Barnes S. Effect of genistein on in vitro and in vivo models of cancer. J Nutr 1995;125:7775-835.
156. Okura A, Arakawa H, Oka H, Yoshinari T, Monden Y. Effect of genistein on topoisomerase activity and on the growth of [val 12]Ha-ras-transformed NIH 3T3 cells. Biochem Biophys Res Commun 1988;157:183-9.
157. Markovits J, Linassier C, Fosse P, et al. Inhibitory effects of the tyrosine kinase inhibitor genistcin on mammalian DNA topoisomerase II. Cancer Res 1989;49:5111-7.
158. Traganos F, Ardelt B, Halko N, Bruno S, Darzynkiewicz Z. Effects of genistein on the growth and cell cycle progression of normal human lymphocytes and human leukemic MOLT-4 and HL-60 cells. Cancer Res 1992;52:6200-8.
159. Matsukawa Y, Marui N, Sakai T, et al. Genistein arrests cell cycle progression at G2-M. Cancer Res 1993;53:1328-31.
160. Higashi K, Ogawara H. Daidzein inhibits insulin- or insulin-like growth factor-1-mediated signaling in cell cycle progression of Swiss 3T3 cells. Biochim Biophys Acta 1994;1220:29-35.
161. Gyorgy P, Murata K, Ikehata H. Antioxidants isolated from fermented soybeans (tempeh). Nature 1964;203:870-2.
162. Jha HC, Von Recklinghausen G, Zilliken F. Inhibition of in vitro microsomal lipid peroxidation by isoflavonoids. Biochem Pharmacol 1985;34:1367-9.
163. Wei H, Bowen R, Cai Q, Barnes S, Wang Y. Antioxidant and antipromotional effects of the soybean isoflavone genistein. Proc Soc Exp Biol Med 1995;208:124-30.
164. Wei H, Cai Q, Rahn RO. Inhibition of UV light- and Fenton reaction-induced oxidative DNA damage by the soybean isoflavone genistein. Carcinogenesis 1996;17:73-7.
165. Hirano T, Oka K, Akiba M. Antiproliferative activity of synthetic and naturally occurring flavonoids on tumor cells of the human breast carcinoma cell line, ZR-75-1. Res Commun Chem Pathol Pharmacol 1989;64:69-78.
166. Yanagihara K, Ito A, Toge T, Numoto M. Antiproliferative effects of isoflavones on human cancer cell lines established from the gastrointestinal tract. Cancer Res 1993;53:5815-21.
167. Schweigerer L, Christeleit K, Fleischmann G, et al. Identification in human urine of a natural growth inhibitor for cells derived from solid paediatric tumors. Eur J Clin Invest 1992;22:260-4.
168. Fotsis T, Pepper M, Adlercreutz H, et al. Genistein, a dietary-derived inhibitor of in vitro angiogenesis. Proc Natl Acad Sci USA 1993;90:2990-4.
169. Wilcox JN, Blumenthal BF. Thrombotic mechanism in atherosclerosis: potential impact of soy proteins. J Nutr 1995;125:631S-8S.
170. Yamamoto S, Shimizu K, Oonishi I, et al. Genistein suppresses cellular injury following hepatic ischemia/reperfusion. Transplant Proc 1996;28:1111-5.
171. Salzman AL, Deneberg AG, Ueta I, O'Connoe M, Linn SC, Szabo C. Induction and activity of nitric oxide synthase in cultured human intestinal epithelial monolayers. Am J Physiol 1996;270:G565-73.
172. Sharma OP, Adlercreutz H, Strandberg JD, Zirkin BR, Coffey DS, Ewing LL. Soy of dietary source plays a preventative role against the pathogenesis of prostatitis in rats. J Steroid Biochem Mol Biol 1992;43:557-64.
173. Kellis JT Jr, Vickery LE. Inhibition of human estrogen synthetase (aromatase) by flavones. Science 1984;225:1032-4.
174. Ibrahim A-R, Abdul-Haj YJ. Aromatase inhibition by flavonoids. J Steroid Biochem Mol Biol 1990;37:257-60.
175. Adlercreutz H, Bannwart C, Wahala K, et al. Inhibition of human aromatase by mammalian lignans and isoflavonoid phytoestrogens. J Steroid Biochem 1993;44:147-53.
176. Wang C, Makela T, Hase T, Adlercreutz H, Kurzer MS. Lignans and flavonoids inhibit aromatase enzyme in human preadipocytes. J Steroid Biochem Mol Med 1993;50:205-12.
177. Adlercreutz H, Hockerstedt K, Bannwart C, et al. Effect of dietary components, including lignans and phytoestrogens, on enterohepatic circulation and liver metabolism of estrogens and on sex hormone binding globulin (SHBG). J Steroid Biochem 1987;27: 1135-44.
178. Mousavi Y, Adlercreutz H. Genistein is an effective stimulator of sex hormone-binding globulin production in hepatocarcinoma human liver cancer cells and suppresses proliferation of these cells in culture. Steroids 1993;58:301-4.
179. Loukovaara M, Carson M, Palotie A, Adlercreutz H. Regulation of sex hormone-binding globulin production by isoflavonoids and patterns of isoflavonoid conjugation in HepG2 cell cultures. Steroids 1995;60:656-61.
180. Henderson D. Aromatase inhibitors: their biochemistry and clinical potential. J Steroid Biochem 1987;27:905-14.
181. Miller WR, O'Neill JS. The relevance of local oestrogen metabolism within the breast. Proc R Soc Edinb 1989;95B:203-17.
182. Martin ME, Haourigui M, Pelissero C, Benassayag C, Nunez EA. Interactions between phytoestrogens and human sex steroid binding protein. Life Sci 1996;58:429-36.
183. Armstrong BK, Brown JB, Clarke HT, et al. Diet and reproductive hormones: a study of vegetarian and nonvegetarian postmenopausal women. J Natl Cancer Inst 1981;67:761-7.
184. Adlercreutz H, Hockerstedt K, Bannwart C, Hamalainen E, Fotsis T, Bloigu S. Association between dietary fiber, urinary excretion of lignans and isoflavonic phytoestrogens, and plasma non-protein bound sex hormones in relation to breast cancer. In: Bresciani F, King RJB, Lippman ME, Raynaud J-P, eds. Progress in cancer research and therapy. New York: Raven Press Ltd, 1988:409-12.
185. Adlercreutz H, Hamalainen E, Gorbach SL, Goldin BR, Woods MN, Dwyer JT. Diet and plasma androgens in postmenopausal vegetarian and omnivorous women and postmenopausal women with breast cancer. Am J Clin Nutr 1989;49:433-42.
186. Shultz TD, Bonorden WR, Seaman WR. Effect of short-term flaxseed consumption on lignan and sex hormone metabolism in men. Nutr Res 1991;11:1089-100.
187. Phipps WR, Martini MC, Lampe JW, Slavin JL, Kurzer M. Effect of flaxseed ingestion on the menstrual cycle. J Clin Endocrinol Metab 1993;77:1215-9.
188. Baird DD, Umbach DM, Lansdell L. et al. Dietary intervention study to assess estrogenicity of dietary soy among postmenopausal women. J Clin Endocrinol Metab 1995;80:1685-90.
189. Treolar AE, Boynton RE, Behn BG, Brown BW. Variation of the human menstrual cycle through reproductive life. Int J Fertil 1970;12:77-126.
190. Henderson BE, Ross RK, Judd HL, Frailo MD, Pike MC. Do regulatory ovulatory cycles increase breast cancer risk? Cancer 1985;56:1206-8.
191. Willis KJ, London DR, Ward HWC, Butt WR. Recurrent breast cancer treated with the antiestrogen tamoxifen: correlation between hormonal changes and clinical course. Br Med J 1977;1:425-8.
192. Jordan VC, Fritz NF, Tormey DC. Endocrine effects of adjuvant chemotherapy and long-term tamoxifen administration on node-positive patients with breast cancer. Cancer Res 1987;47:624-30.
193. Powles TJ, Hardy JR, Ashley SE, et al. A pilot trial to evaluate the acute toxicity and feasibility of tamoxifen for prevention of breast cancer. Br J Cancer 1989;60:126-31.
194. Evans BAJ, Griffiths K, Morton MS. Inhibition of 5α-reductase in genital skin fibroblasts and prostate tissue by dietary lignans and isoflavonoids. J Endocrinol 1995;147:295-302.
195. Ross RK, Bernstein L, Lobo RA, et al. 5-Alpha-reductase activity and risk of prostate cancer among Japanese and US white and black males. Lancet 1992;339:887-9.
196. Makela SI, Pylkkanen LH, Santti RS, Adlercreutz H. Role of plant estrogens in normal and estrogen-related altered growth of the mouse prostate. Proceedings of the Interdisciplinary Conference on Effects of Food on the Immune and Hormonal Systems: Euro Food Tox III. Schwerzenbach, Switzerland: Institute of Toxicology, Swiss Federal Institute of Technology & University of Zurich, 1991:135-9.
197. Carroll KK. Review of clinical studies on cholesterol-lowering response to soy protein. J Am Diet Assoc 1991;91:820-7.
198. Kritchevsky D. Dietary protein, cholesterol and atherosclerosis: a review of the early history. J Nutr 1995;125:589S-93S.
199. Anderson JW, Johnstone BM, Cook-Newell ME. Meta-analysis of the effects of soy protein intake on serum lipids. N Engl J Med 1995;333:272-86.
200. Love RR, Newcomb PA, Weibe DA, et al. Effects of tamoxifen on plasma lipid and lipoprotein levels in postmenopausal patients with negative breast cancer. J Natl Cancer Inst 1991;82:1327-32.
201. Dnistrian AM, Schwartz MK, Greenberg EJ, Smith CA, Schwartz DC. Effect of
202. Jordan VC. The only true antiestrogen is a no estrogen. Mol Cell Endocrinol 1990;74:C91.
203. Walsh BW, Schiff I, Rosner B, Greenberg L, Ravnikar V, Sacks FM. Effects of postmenopausal estrogen replacement on the concentrations and metabolism of plasma lipoproteins. N Engl J Med 1991;325:1196-204.
204. Potter SM. Overview of proposed mechanisms for the hypocholesterolemic effect of soy. J Nutr 1995;125:606S-11S.
205. Anthony MS, Clarkson TB, Hughes CL, Plant and mammalian estrogen effects on plasma lipids of female monkeys. Circulation 1994;90(suppl):1-235.
206. Anthony MS, Clarkson TB, Hughes CL, Moregan TM, Burke GL. Soybean isoflavones improve cardiovascular risk factors without affecting the reproductive system of peripubertal rhesus monkeys. J Nutr 1996;126:43-50.
207. Anthony MS, Clarkson TB, Weddle DL, Wolfe MS. Effects of soy protein phytoestrogens on cardiovascular risk factors in rhesus monkeys. J Nutr 1995;125:803S-4S.
208. Raines EW, Ross R. Biology of atherosclerotic plaque formation: possible role of growth factors in lesion development and the impact of soy. J Nutr 1995;125:624S-30S.
209. Keys A. Seven countries: a multivariant analysis of death and coronary heart disease. Cambridge, MA: Harvard University Press, 1980.
210. Steinberg D, Witzum JL. Lipoproteins and atherogenesis: current concepts. JAMA 1990;264:3047-52.
211. Cassidy A, Faughnan M, Hughes R, et al. Hormonal effects of phytoestrogens in postmenopausal women and middle aged men. Br J Nutr (in press).
212. Lock M. Contested meanings of the menopause. Lancet 1991; 337:1270-2.
213. Wilcox G, Wahlqvist ML, Burger HG, Medley G. Oestrogenic effects of plant foods in postmenopausal women. Br Med J 1990;301:905-6.
214. Murkies AL, Lombard C, Strauss BJG, Wilcox G, Burger HG, Morton MS. Dietary flour supplementation decreases post-menopausal hot flushes: effect of soy and wheat. Maturitas 1995;21:189-95.
215. Cline JM, Paschold JC, Anthony MS, Obasanjo IO, Adams MR. Effects of hormonal therapies and dietary soy phytoestrogens on vaginal cytology in surgically postmenopausal macaques. Fertil Steril 1996;65:1031-5.
216. Cooper C, Campion G, Melton LJ III. Hip fractures in the elderly: a world-wide projection. Osteoporos Int 1992:285-9.
217. WHO Study Group Report. Assessment of fracture risk and its application to screening for postmenopausal osteoporosis. WHO Tech Rep Ser 1994;843:11-3.
218. Komm BS, Tepening CM, Benz DJ, et al. Estrogen binding, receptor mRNA, and biological response in osteoblast-like osteocarcinoma cells. Science 1988;241:81-4.
219. Eriksen EF, Colvard DS, Berg NJ, et al. Evidence of estrogen receptors in normal human osteoblast-like cells. Science 1988;241:84-6.
220. Brandi ML. New treatment strategies: ipriflavone, strontium, vitamin D metabolites, and analogs. Am J Med 1993;95:69S-74S.
221. Yoshida K, Tsukamoto T, Torii H, et al. Metabolism of ipriflavone (TC-80) in rats. Radioisotopes 1985;34:612-7.
222. Anderson JJ, Ambrose WW, Garner SC. Orally dosed genistein from soy and prevention of cancellous bone loss in two ovariectomized rat models. J Nutr 1995;125:7995.
223. Arjmandi BH, Alekel L, Hollis BW, et al. Dietary soybean protein prevents bone loss in an ovariectomized rat model of osteoporosis. J Nutr 1996;126:161-7.
224. Keung W-M. Biochemical studies of a new class of alcohol dehydrogenase inhibitors from Radix puerariac. Alcohol Clin Exp Res 1993;17:1254-60.
225. Keung W-M, Vallee BL. Daidzin: a potent inhibitor of human mitochondrial aldehyde dehydrogenase. Proc Natl Acad Sci USA 1993; 90:1247-51.
226. Xie C-I, Lin RC, Anthony V, et al. Daidzin, an antioxidant isoflavonoid, decreases blood alcohol levels and shortens sleep time induced by ethanol intoxication. Alcohol Clin Exp Res 1994;18:1443-7.